MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study
Zhang, Qing Yuan, Sun, Tao, Yin, Yong Mei, Li, Hui Ping, Yan, Min, Tong, Zhong Sheng, Oppermann, Christina P., Liu, Yun Peng, Costa, Romulo, Li, Man, Cheng, Ying, Ouyang, Qu Chang, Chen, Xi, Liao, Ning, Wu, Xin Hong, Wang, Xiao Jia, Feng, Ji Feng, Hegg, Roberto, Kanakasetty, G.B., Coccia-Portugal, Maria A., Han, Ru Bing, Lu, Yi, Chi, Hai Dong, Jiang, Ze Fei, Hu, Xi Chun
Published in Therapeutic advances in medical oncology (2020)
Published in Therapeutic advances in medical oncology (2020)
Get full text
Journal Article
Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer： efficacy, safety, and biomarker results from Chinese patients
Xu, Bing-He, Jiang, Ze-Fei, Chua, Daniel, Shao, Zhi-Min, Luo, Rong-Cheng, Wang, Xiao-Jia, Liu, Dong-Geng, Yeo, Winnie, Yu, Shi-Ying, Newstat, Beth, Preston, Alka, Martin, Anne-Marie, Chi, Hai-Dong, Wang, Li
Published in Ai zheng (01.05.2011)
Published in Ai zheng (01.05.2011)
Get full text
Journal Article
Consistent efficacy and safety of gemcitabine-paclitaxel in patients with metastatic breast cancer: A retrospective comparison of East Asian and global studies
Xu, Binghe, Zhang, Xiao Qing, Chi, Hai Dong, Liu, Zhixin, Quinlivan, Mitchell, Orlando, Mauro
Published in Asia-Pacific journal of clinical oncology (01.12.2014)
Published in Asia-Pacific journal of clinical oncology (01.12.2014)
Get full text
Journal Article
Consistent efficacy and safety of gemcitabine-paclitaxel in patients with metastatic breast cancer: A retrospective comparison of East Asian and global studies: Ethnicity effect in metastatic breast cancer
Xu, Binghe, Zhang, Xiao Qing, Chi, Hai Dong, Liu, Zhixin, Quinlivan, Mitchell, Orlando, Mauro
Published in Asia-Pacific journal of clinical oncology (01.12.2014)
Published in Asia-Pacific journal of clinical oncology (01.12.2014)
Get full text
Journal Article